According to the Zhitong Finance App, FuRui Medical Technology (01696.HK) announced its 2026 interim results, with revenue of approximately US$171.4 million, an increase of 3.6% over the previous year. The owner of the parent company should have accounted for a loss of US$1.155 million, a year-on-year profit to loss; loss of 0.25 US cents per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.